Raja Elina Ahmad

Dr. Raja Elina Ahmad

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in International Journal of Medical Sciences
Verified
Journal Article
Open access
SNSangeetha Vasudevaraj Naveen
Sangeetha Vasudevaraj Naveen
RARaja Elina Ahmad
Raja Elina Ahmad
WHWong Jia Hui
Wong Jia Hui
ASAbdulrazzaq Mahmod Suhaeb
Abdulrazzaq Mahmod Suhaeb
MMMalliga Raman Murali
Malliga Raman Murali
TKTunku Kamarul
Tunku Kamarul
Monosodium -iodoacetate (MIA)-induced animal model of osteoarthritis (OA) is under-utilised despite having many inherent advantages. At present, there is lack of studies that directly compare the degenerative changes induced by MIA with the surgical osteoarthritis induction method and human osteoarthritis, which would further verify a greater use of this model. Therefore, we compared the histological, biochemical and biomechanical characteristics in rat model using MIA against the anterior cruciate ligament transection (ACLT) and human cartilage with clinically established osteoarthritis. The right knees of Sprague-Dawley rats were subjected to either MIA or ACLT (n=18 in each group). Six rats were used as controls. Human cartilage samples were collected and compared from patients clinically diagnosed with (n=7) and without osteoarthritis (n=3). Histological, biochemical (Glycosaminoglycans/total protein) and biomechanical (cartilage stiffness) evaluations were performed at the end of the 1st and 2nd week after OA induction. For human samples, evaluations were performed at the time of sampling. Histopathological changes in the MIA group were comparable to that observed in the ACLT group and human OA. The Mankin scores of the 3 groups were comparable (MIA: 11.5±1.0; ACLT: 10.1±1.1; human OA: 13.2±0.8). Comparable reduction in Glycosaminoglycan/total protein content in the intervention groups were observed (MIA: 7±0.6; ACLT: 6.6±0.5; human OA: 3.1±0.7). Cartilage stiffness score were 24.2±15.3 Mpa for MIA, 25.3±4.8 for ACLT and 0.5±0.0 Mpa for human OA. The MIA model produces comparable degenerative changes to ACLT and human OA with the advantage of being rapid, minimally invasive and reproducible. Therefore, wider utilisation of MIA as animal translational OA model should perhaps be advocated.

20 September 2023 in Joint Bone Spine
Verified
Journal Article
Closed access
PKPeggy Kong
Peggy Kong
RARaja Elina Ahmad
Raja Elina Ahmad
AZAmirah Zulkifli
Amirah Zulkifli
SKShaliny Krishnan
Shaliny Krishnan
HNHui Yin Nam
Hui Yin Nam
TKTunku Kamarul
Tunku Kamarul

7 September 2016 in PeerJ
Verified
Journal Article
Open access
PDF file
SSShani Samuel
Shani Samuel
RARaja Elina Ahmad
Raja Elina Ahmad
TRThamil Selvee Ramasamy
Thamil Selvee Ramasamy
PKPuvanan Karunanithi
Puvanan Karunanithi
SNSangeetha Vasudevaraj Naveen
Sangeetha Vasudevaraj Naveen
TKTunku Kamarul
Tunku Kamarul
Previous studies have shown that platelet concentrates used in conjunction with appropriate growth media enhance osteogenic differentiation of human mesenchymal stromal cells (hMSCs). However, their potential in inducing osteogenesis of hMSCs when cultured in serum free medium has not been explored. Furthermore, the resulting osteogenic molecular signatures of the hMSCs have not been compared to standard osteogenic medium. We studied the effect of infrequent supplementation (8-day interval) of 15% non-activated platelet-rich concentrate (PRC) in serum free medium on hMSCs proliferation and differentiation throughout a course of 24 days, and compared the effect with those cultured in a standard osteogenic medium (OM). Cell proliferation was analyzed by alamar blue assay. Gene expression of osteogenic markers (Runx2, Collagen1, Alkaline Phosphatase, Bone morphogenetic protein 2, Osteopontin, Osteocalcin, Osteonectin) were analyzed using Q-PCR. Immunocytochemical staining for osteocalcin, osteopontin and transcription factor Runx2 were done at 8, 16 and 24 days. Biochemical assays for the expression of ALP and osteocalcin were also performed at these time-points. Osteogenic differentiation was further confirmed qualitatively by Alizarin Red S staining that was quantified using cetylpyridinium chloride. Results showed that PRC supplemented in serum free medium enhanced hMSC proliferation, which peaked at day 16. The temporal pattern of gene expression of hMSCs under the influence of PRC was comparable to that of the osteogenic media, but at a greater extent at specific time points. Immunocytochemical staining revealed stronger staining for Runx2 in the PRC-treated group compared to OM, while the staining for Osteocalcin and Osteopontin were comparable in both groups. ALP activity and Osteocalcin/DNA level were higher in the PRC group. Cells in the PRC group had similar level of bone mineralization as those cultured in OM, as reflected by the intensity of Alizarin red stain. Collectively, these results demonstrate a great potential of PRC alone in inducing proliferation of hMSCs without any influence from other lineage-specific growth media. PRC alone has similar capacity to enhance hMSC osteogenic differentiation as a standard OM, without changing the temporal profile of the differentiation process. Thus, PRC could be used as a substitute medium to provide sufficient pool of pre-differentiated hMSCs for potential clinical application in bone regeneration.

1 April 2018 in Injury
Verified
Journal Article
Closed access
SSShani Samuel
Shani Samuel
RARaja Elina Ahmad
Raja Elina Ahmad
TRThamil Selvee Ramasamy
Thamil Selvee Ramasamy
FMFaizal Manan
Faizal Manan
TKTunku Kamarul
Tunku Kamarul

20 March 2023 in Tissue and Cell
Verified
Journal Article
Closed access
AZAmirah Zulkifli
Amirah Zulkifli
RARaja Elina Ahmad
Raja Elina Ahmad
SKShaliny Krishnan
Shaliny Krishnan
PKPeggy Kong
Peggy Kong
HNHui Yin Nam
Hui Yin Nam
TKTunku Kamarul
Tunku Kamarul

1 November 2017 in Platelets
Verified
Journal Article
Closed access
SSShani Samuel
Shani Samuel
RARaja Elina Ahmad
Raja Elina Ahmad
TRThamil Selvee Ramasamy
Thamil Selvee Ramasamy
PKPuvanan Karunanithi
Puvanan Karunanithi
SNSangeetha Vasudevaraj Naveen
Sangeetha Vasudevaraj Naveen
TKTunku Kamarul
Tunku Kamarul
Platelet-rich concentrate (PRC), used in conjunction with other chondroinductive growth factors, have been shown to induce chondrogenesis of human mesenchymal stromal cells (hMSC) in pellet culture. However, pellet culture systems promote cell hypertrophy and the presence of other chondroinductive growth factors in the culture media used in previous studies obscures accurate determination of the effect of platelet itself in inducing chondrogenic differentiation. Hence, this study aimed to investigate the effect of PRC alone in enhancing the chondrogenic differentiation potential of human mesenchymal stromal cells (hMSC) encapsulated in three-dimensional alginate constructs. Cells encapsulated in alginate were cultured in serum-free medium supplemented with only 15% PRC. Scanning electron microscopy was used to determine the cell morphology. Chondrogenic molecular signature of hMSCs was determined by quantitative real-time PCR and verified at protein levels via immunohistochemistry and enzyme-linked immunosorbent assay. Results showed that the cells cultured in the presence of PRC for 24 days maintained a chondrocytic phenotype and demonstrated minimal upregulation of cartilaginous extracellular matrix (ECM) marker genes (SOX9, TNC, COL2, ACAN, COMP) and reduced expression of chondrocyte hypertrophy genes (Col X, Runx2) compared to the standard chondrogenic medium (p < 0.05). PRC group had correspondingly higher levels of glycosaminoglycan and increased concentration of chondrogenic specific proteins (COL2, ACAN, COMP) in the ECM. In conclusion, PRC alone appears to be very potent in inducing chondrogenic differentiation of hMSCs and offers additional benefit of suppressing chondrocyte hypertrophy, rendering it a promising approach for providing abundant pool of chondrogenic MSCs for application in cartilage tissue engineering.